— Published date: 6/2/2026
Value proposition: CAR-engineered cDC1 cells (syngeneic or allogeneic) that stably express a proprietary, modular chimeric antigen receptor and demonstrate strong in vivo efficacy against solid tumors, including immunologically ‘cold’ tumors.
Technology Desc…
— Published date: 4/21/2026
Value Proposition: IL-15 superagonist that utilizes a companion diagnostic to treat atopic dermatitis.
Technology Description
Researchers at Washington University in St. Louis have developed a treatment strategy for atopic dermatitis that uses an IL-15 superagonist, al…
— Value Proposition: This invention uses a novel gene therapy that blocks the axon degeneration typical of neurodegenerative diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a new strategy for treatment of neurodegenerative diseases with axonopathy.…
— Published date: 2/10/2026
Value Proposition: Novel non-invasive multielectrode transcutaneous spinal cord stimulation (tSCS) technique capable of selectively activating specific joints.
Technology Description
Researchers at Washington University in St. Louis have developed a new non-invasive s…
| Name | # Summaries | Author | Action |
|---|---|---|---|
| 15 | |||
| 13 | |||
| 1 | |||
| 15 | |||
| 26 | |||
| 14 | |||
| 14 |
Creating...
